Inquiry Basket
Scientists around the world are seriously studying SARS-CoV-2, a coronavirus that causes COVID-19. BOC RNA is working together with the industry to provide the expertise needed to mitigate global emergencies and help develop effective therapies.
Relying on our liposome platform, we are committed to solving the problem of in vivo delivery of small molecule drugs/vaccines for COVID-19 treatment/prevention to promote the rapid generation of treatment tools needed to reduce pandemics.
We provide liposomes loaded with drugs or vaccines. We can load it into liposomes based on the mRNA vaccine developed in cooperation. If you already have drug candidates, we can provide liposome encapsulation services and help you prepare loaded liposomes.
Since the emergence of the COVID-19, BOC RNA has increased its efforts. We will continue to maintain industry cooperation to achieve the greatest chance of success.
More Information
Other COVID-19 Related Services
COVID-19 mRNA Vaccine Development Services
Custom Oligo Synthesis Services For COVID-19 Research
COVID-19 Resources & News
| ||
Will the mRNA vaccine become the “savior” of COVID-19？ Cell Immunity: SARS-CoV-2 vaccines status bioRxiv.: Scientists Find siRNA drugs that may inhibit SARS-CoV-2 | ||
Global Supplier of High-Quality RNA / DNA Products & Services.
